4D Molecular Therapeutics (FDMT) Share-based Compensation (2020 - 2026)
4D Molecular Therapeutics' Share-based Compensation was $5.88 million in Q2 2026, up 18.7% from $4.96 million a year earlier and up 32.1% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Share-based Compensation (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, 4D Molecular Therapeutics' Share-based Compensation was $20.41 million through Jun 30, 2026, down 21.5% year-over-year; for FY2025, it came in at $22.02 million, down 15.7% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 34.6% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $26.12 million in FY2024 (+32.8%), $19.67 million in FY2023 (+14.9%), $17.12 million in FY2022 (+24.1%) and $13.8 million in FY2021 (+176.9%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation since Q1 2025.
- Compared with a year earlier, Share-based Compensation was higher in four of the last eight quarters, with an average decline of 0.7%.
- The best year-over-year quarter for Share-based Compensation over five years was Q3 2021 (growth of 242.0%); the worst was Q1 2026 (a decline of 36.3%).
- Per Business Quant data, FDMT's Share-based Compensation in the three quarters before Q2 2026 was $4.45 million (Q1 2026), $5.55 million (Q4 2025) and $4.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | 4D Molecular Therapeutics | 1.02 Bn | -436.78 Mn | - | 5.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.88 Mn |
| Mar 31, 2026 | 4.45 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 4.52 Mn |
| Jun 30, 2025 | 4.96 Mn |
| Mar 31, 2025 | 6.99 Mn |
| Dec 31, 2024 | 7.58 Mn |
| Sep 30, 2024 | 6.49 Mn |
| Jun 30, 2024 | 6.07 Mn |
| Mar 31, 2024 | 5.97 Mn |
| Dec 31, 2023 | 5.91 Mn |
| Sep 30, 2023 | 4.56 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Mar 31, 2023 | 4.22 Mn |
| Dec 31, 2022 | 4.35 Mn |
| Sep 30, 2022 | 4.52 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Mar 31, 2022 | 3.93 Mn |
| Dec 31, 2021 | 3.73 Mn |
| Sep 30, 2021 | 3.92 Mn |
API Access
4D Molecular Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();